Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-centre, Adaptive, Randomized, Double-blind, Placebo-controlled Comparative Clinical Study of the Safety and Efficacy of Polyoxidonium®, Lyophilizate for Solution for Injections and Topical Application, 6 mg (NPO Petrovax Pharm LLC, Russia) in Patients With Coronavirus Disease (COVID-19).

NCT04381377 is registered in ClinicalTrials.gov with NPO Petrovax as lead sponsor.

NCT NCT04381377
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04381377 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-centre, Adaptive, Randomized, Double-blind, Placebo-controlled Comparative Clinical Study of the Safety and Efficacy of Polyoxidonium®, Lyophilizate for Solution for Injections and Topical Application, 6 mg (NPO Petrovax Pharm LLC, Russia) in Patients With Coronavirus Disease (COVID-19).
Lead sponsor
NPO Petrovax
Phase
Phase 2/3
Overall status
Completed
Start date
April 28, 2020
Completion date
April 23, 2021
Enrollment
394 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

infections, coronavirus